VLDLR and neoplasm: Overexpression of PPARα and PPARβ/δ promoted the expression of lipid transporter protein CD36 and low-density lipoprotein receptor, which increased the uptake and accumulation of lipids by NK cells, leading to a decrease in the secretion of effector cytokines by NK cells and a decrease in the ability of tumor cells to lyse (86).